Phase II Trial of an Orelabrutinib-Based Combination Therapy in Newly Diagnosed Primary Central Nervous System Lymphoma
Yajing Zhao(The Affiliated Yongchuan Hospital of Chongqing Medical University), Ji Ma(Shandong First Medical University), Qiang He(Zhejiang Chinese Medical University), Guoqiang Liu(Ministry of Ecology and Environment), Xinguang Liu(Qilu Hospital of Shandong University), Lei Xu(Nanjing Medical University), Caifeng Sun(Nanjing Maternity and Child Health Care Hospital), Yafei Yu(Urbana University)
Cited by 0
Related Papers
Assessing the Use of Probes and Quenchers for Understanding the Reactive Species in Advanced Oxidation Processes
|Environmental Science & Technology|2023|588
Natural polyphenols enhanced the Cu(II)/peroxymonosulfate (PMS) oxidation: The contribution of Cu(III) and HO•
|Water Research|2020|252
A novel peroxymonosulfate (PMS)-enhanced iron coagulation process for simultaneous removal of trace organic pollutants in water
|Water Research|2020|124
A novel in vitro method to model the fate of subcutaneously administered biopharmaceuticals and associated formulation components
|Journal of Controlled Release|2015|115
Rate Constants and Mechanisms for Reactions of Bromine Radicals with Trace Organic Contaminants
|Environmental Science & Technology|2021|101